News

Radiographic vertebral fractures common in ankylosing spondylitis patients


 

FROM ARTHRITIS CARE & RESEARCH

References

Radiographic vertebral fractures occur frequently in patients with ankylosing spondylitis, according to Dr. Fiona Maas and her associates.

At baseline, 59 (20%) of the 292 patients included in a prospective cohort study had radiographic vertebral fractures. During a 2-year follow-up period, 15 patients developed new fractures and 7 patients experienced an increase in severity of current fractures. A significant majority of fractures were defined as mild, and most were located in the mid-thoracic and thoracolumbar regions of the spine.

Fractures were more likely in patients who were older, had a higher body mass index, had smoked for long durations, had larger occiput-to-wall distances, had more spinal radiographic damage, and had lower hip bone mineral density (BMD). Patients who developed new fractures during the study period were older and had lower hip BMD. Incidence and prevalence of fractures was reduced in patients who were receiving nonsteroidal anti-inflammatory drugs (NSAIDs) at baseline.

“The influence of anti-inflammatory drugs (e.g. NSAIDs, TNF-alpha inhibitors), anti-osteoporotic treatment (e.g. calcium/vitamin D supplements, bisphosphonates), and lifestyle changes (e.g. smoking cessation, body weight control, physical exercise) on the development of vertebral fractures in AS should be further investigated in a large study population with long-term follow-up,” the investigators concluded.

Find the full study in Arthritis Care & Research (doi: 10.1002/acr.22980).

lfranki@frontlinemedcom.com

Recommended Reading

Study: TNF inhibitors improve extraintestinal IBD manifestations
MDedge Rheumatology
Genetic therapy lowers joint bleeding in hemophilia B
MDedge Rheumatology
Obesity may attenuate anti-TNF response in psoriatic arthritis
MDedge Rheumatology
NSAID plus TNFi linked to less ankylosing spondylitis progression
MDedge Rheumatology
NSAID plus TNFi linked to less ankylosing spondylitis progression
MDedge Rheumatology
Analysis supports daily folate for children with psoriasis on methotrexate
MDedge Rheumatology
Pharma jousts statistically for an ankylosing spondylitis edge
MDedge Rheumatology
Adalimumab approved to treat noninfectious uveitis
MDedge Rheumatology
Severe psoriasis upped lymphoma risk in large cohort study
MDedge Rheumatology
FDA’s arthritis advisory committee unanimously backs biosimilar Humira
MDedge Rheumatology